There’s a tiny peptide you may never have heard of that’s garnering a lot of interest in the fields of aging, metabolism and neurodegeneration.
For those of us carrying APOE4, I believe it’s of particular interest.
It’s called Humanin.
Humanin is only 24 amino acids long, yet research suggests that this tiny molecule may influence mitochondrial function, inflammation, insulin sensitivity, cellular stress responses and potentially protection against amyloid toxicity.
Even more intriguing, researchers recently identified a naturally occurring Humanin variant associated with exceptional longevity in APOE4 carriers.
So what exactly is Humanin and could this little mitochondrial signal tell us something important about healthy brain aging?
What Is Humanin?
Humanin is a mitochondrial-derived peptide (MDP).
Unlike most proteins we talk about, which are encoded by DNA in the cell nucleus, Humanin is encoded within mitochondrial DNA.
Mitochondrial-derived peptides such as Humanin and MOTS-c appear to act as signaling molecules, allowing mitochondria to influence metabolism, inflammation, cellular stress responses and survival throughout the body.
Humanin is one of those signals.
Our bodies produce it naturally, and while circulating Humanin can be measured in blood - unfortunately, it’s not something we can get during a routine lab test.
Synthetic Humanin and more potent analogs such as S14G-Humanin (HNG) are also being studied experimentally. Humanin is not FDA-approved as a treatment for any conditions in humans, and much of the intervention research remains preclinical.
But the biology is truly fascinating and exciting.
Humanin and Brain Health
Humanin was originally discovered because of its ability to protect neurons against Alzheimer’s-related cellular stress.
Experimental research suggests Humanin can:
Protect neurons from cellular stress
Reduce apoptosis, or programmed cell death
Protect against amyloid-beta toxicity
Support mitochondrial function
Reduce inflammatory signaling
Influence insulin signaling
Support cellular resilience during metabolic and oxidative stress
One of Humanin’s mechanisms is particularly interesting.
Humanin can interact with BAX, a protein involved in triggering mitochondrial apoptosis. By interfering with BAX activation and movement into mitochondria, Humanin can interrupt part of the cellular pathway leading to cell death.
In other words, Humanin appears to function partly as a mitochondrial distress-response signal.
Humanin and Alzheimer’s Disease
Humanin has repeatedly demonstrated neuroprotective effects in laboratory and animal models of Alzheimer’s disease.
Research suggests that Humanin and its analogs can:
Reduce amyloid-beta toxicity
Increase neuronal survival
Improve insulin signaling in the brain
Increase autophagy
Reduce amyloid accumulation in some animal models
Influence inflammatory and phagocytic pathways involved in clearing cellular debris
This does not mean Humanin has been demonstrated to prevent or treat Alzheimer’s disease in humans - because it hasn’t. But it does raise an interesting possibility.
Could declining mitochondrial stress defenses be one of the factors that makes the aging brain increasingly vulnerable to Alzheimer’s pathol
The APOE4 Connection Gets Really Interesting
For APOE4 carriers, a remarkable Humanin finding was published in Aging Cell in 2024.
Researchers identified a naturally occurring Humanin variant called P3S that was enriched among exceptionally long-lived APOE4 carriers.
Even more remarkably, when researchers tested Humanin P3S in an APOE4 mouse model of amyloidosis, it reduced brain amyloid-beta accumulation compared with ordinary Humanin.
The researchers found evidence suggesting that P3S may improve amyloid phagocytosis and clearance.
They also found that the P3S version of Humanin appears to interact particularly strongly with the APOE4 protein.
Think about the implication.
APOE4 is the strongest common genetic risk factor for late-onset Alzheimer’s disease.
Yet some APOE4 carriers reach extreme old age cognitively intact.
A mitochondrial peptide variant may be one piece of the biological resilience that allows some people to withstand APOE4-associated pathology.
Humanin, Astrocytes and GFAP
Another intriguing piece of the story involves astrocytes.
Astrocytes are support cells in the brain that help regulate metabolism, inflammation, neurotransmitters and neuronal health.
When astrocytes become reactive, expression of GFAP (glial fibrillary acidic protein) often increases. Plasma GFAP is now being studied as a blood biomarker of astrocytic activation in Alzheimer’s disease and other neurological conditions.
In a 2013 laboratory experiment, researchers activated astrocytes with LPS, causing inflammatory signaling and GFAP expression to increase.
Humanin treatment suppressed astrocyte activation in a dose-dependent manner and reduced inflammatory signals including IL-6, IL-1β and TNF-α.
More recently, an animal study of traumatic brain injury found increases in GFAP and p-STAT3 following brain injury. Humanin treatment counteracted those increases.
This does not establish that taking Humanin will lower plasma GFAP in humans.
But it raises a fascinating possibility:
Humanin → improved mitochondrial stress response → reduced inflammatory signaling → less astrocyte reactivity → potentially lower GFAP
That pathway deserves considerably more research.
Humanin and Macular Degeneration
Then I came across another intriguing connection: age-related macular degeneration (AMD).
Researchers measured circulating Humanin in people with AMD and healthy controls and found significantly lower Humanin levels in the AMD group.
They then studied retinal pigment epithelial cells containing mitochondrial DNA derived from AMD patients.
When the researchers treated those cells with the potent Humanin analog HNG, inflammatory proteins declined, including:
TNF-α
IL-1β
IFN-γ
IL-17A
ICAM-1
E-selectin
P-selectin
This experiment is especially interesting because the cells were designed so that their nuclear background was identical while their mitochondrial DNA differed.
That points directly toward mitochondrial dysfunction as a driver of the inflammatory phenotype - and toward Humanin as a potential mitochondrial stress-response signal capable of modifying it.
Again, this was not a clinical trial showing that Humanin treats AMD. Yet, it provides another example of the same pattern:
Mitochondrial dysfunction → inflammation
and
Humanin signaling → reduced cellular stress and inflammation
Humanin and Insulin Sensitivity
The metabolic side of Humanin may be just as interesting as its neurological effects.
Humanin and its analogs have improved insulin sensitivity and glucose homeostasis in animal experiments.
Experiments using sophisticated glucose-clamp techniques found that Humanin signaling could improve whole-body insulin sensitivity and suppress excessive hepatic glucose production.
Interestingly, some of this effect appears to originate in the hypothalamus, suggesting communication between mitochondrial signaling in the brain and glucose regulation in the liver.
Humanin analogs have also:
Improved peripheral insulin sensitivity
Increased glucose-stimulated insulin secretion
Protected pancreatic beta cells from cellular stress
Reduced hepatic triglyceride accumulation in animal models
That creates another potential Alzheimer’s connection.
Insulin resistance, impaired cerebral glucose metabolism and mitochondrial dysfunction are all associated with brain aging and Alzheimer’s disease.
Humanin therefore sits at an intriguing intersection:
mitochondria + insulin signaling + inflammation + neuronal survival.
Humanin and Aging
Humanin levels appear to change with aging, and the Humanin pathway has attracted considerable interest from longevity researchers.
Experimental studies have associated Humanin signaling with:
Improved metabolic health
Greater insulin sensitivity
Protection from oxidative stress
Reduced cellular apoptosis
Cardiovascular protection
Neuroprotection
And the discovery of the Humanin P3S variant in exceptionally long-lived APOE4 carriers makes the longevity connection particularly intriguing.
Perhaps Humanin isn’t simply a peptide involved in Alzheimer’s disease.
It may represent part of a broader mitochondrial resilience system that helps determine how successfully cells tolerate the accumulated stresses of aging.
A Different Way to Think About Alzheimer’s
For decades, Alzheimer’s research has focused heavily on amyloid plaques and tau tangles.
Those remain central components of Alzheimer’s biology.
But zoom out and another picture emerges:
Mitochondrial dysfunction
Impaired energy metabolism
Insulin resistance and metabolic stress
Oxidative stress
Inflammation and reactive astrocytes
Reduced ability to withstand or clear cellular damage
Amyloid and tau may exist within this much larger biological environment.
Humanin is interesting because it appears to touch several parts of that environment simultaneously.
For APOE4 carriers - we already appear to have vulnerabilities involving lipid metabolism, mitochondrial function, inflammation and cellular stress - that deserves attention.
Instead of only asking:
“How do we remove the damage once it appears?”
perhaps we should also be asking:
“How do we make our cells more resilient so that they can handle the damage in the first place?”
Can We Increase Humanin Naturally?
This is where the science becomes much less certain.
Exercise and metabolic stress have been investigated in relation to mitochondrial-derived peptide signaling, and interventions that improve mitochondrial health are biologically attractive.
But I would be cautious about claiming that exercise, fasting or particular supplements reliably increase circulating Humanin in humans until we have stronger clinical evidence. Although I did come across one study that supported exercise.
The broader strategies remain worthwhile regardless:
Exercise
Maintaining insulin sensitivity
Maintaining muscle mass
Avoiding chronic metabolic dysfunction
Supporting cardiovascular health
Maintaining mitochondrial fitness
Whether part of their benefit ultimately turns out to involve Humanin remains an intriguing research question.
What About Taking Humanin?
Synthetic Humanin and Humanin analogs are available through some peptide and research-compound sources.
But this is where enthusiasm needs to be separated from evidence.
Humanin is not an FDA-approved anti-aging or Alzheimer’s therapy. And while I’ve personally used some peptides that aren’t FDA approved for human use, it’s a very calculated risk I take in light of my APOE4/4 status and age. I’m NOT suggesting or advocating anyone else do that. I write this post for educational purposes only.
Most of the exciting intervention data come from cells and animals. We do not have robust human clinical trials establishing an appropriate dose, route, long-term safety profile or evidence that administering Humanin prevents cognitive decline.
Something can be biologically fascinating without yet being clinically proven. And since there’s no a big windfall for any pharma company to pursue commercially - any extensive research is unlikely.
My Takeaway
Humanin is only 24 amino acids long.
Yet this tiny mitochondrial peptide appears experimentally connected to:
mitochondrial resilience
insulin sensitivity
inflammatory signaling
astrocyte activation
neuronal survival
amyloid toxicity and clearance
APOE4 resilience
longevity
That is an extraordinary amount of biology packed into a very small peptide.
But for those of us interested in APOE4 and prevention, Humanin is absolutely a molecule worth knowing about - and watching as the research evolves and develops.
References: